Brief: Richter-Helm Biologics expands deal to support COVID-19 DNA vaccine trials

Gedeon Richter

30/04/2020 07:02

April 30 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
    * RICHTER-HELM BIOLOGICS AND INOVIO TO EXPAND EXISTING DNA
MANUFACTURING AGREEMENT TO SUPPORT LARGE-SCALE MANUFACTURING OF
INOVIO'S INVESTIGATIONAL DNA VACCINE FOR COVID-19
    * RICHTER SAYS INOVIO'S INO-4800 IS CURRENTLY IN PHASE 1
CLINICAL
TESTING IN THE U.S. AND COULD POTENTIALLY ADVANCE TO PHASE 2/3
EFFICACY TRIALS THIS SUMMER -STATEMENT

Further company coverage:  GDRB.BU  INO.A  INO.O 

 (Reporting by Gergely Szakacs)
 ((gergely.szakacs@reuters.com ; https://twitter.com/szakacsg ;
+36 1 882 3606 ;
https://www.reuters.com/journalists/gergely-szakacs))